U.S. Life Sciences Stock News

NasdaqGS:QFIN
NasdaqGS:QFINConsumer Finance

Top Dividend Stocks To Consider In June 2026

The United States market has remained flat over the last week but is up 26% over the past year, with earnings expected to grow by 16% annually. In this context of robust growth expectations, dividend stocks can offer a compelling blend of income and potential capital appreciation, making them an attractive option for investors seeking stability and returns.
NasdaqGS:TENB
NasdaqGS:TENBSoftware

Is It Time To Reassess Tenable Holdings (TENB) After The Recent Share Price Surge

Wondering whether Tenable Holdings at around US$29.29 is starting to look like value, or if the stock still carries more risk than reward. The share price has moved sharply in the short term, with returns of 12.9% over the past week and 39.3% over the past month, while year to date the stock is up 28.9%. However, it has fallen 10.0% over the past year, 26.5% over three years and 31.9% over five years. Recent coverage has focused on Tenable Holdings as a cybersecurity platform provider, with...
NYSE:FUN
NYSE:FUNHospitality

A Look At Six Flags Entertainment (FUN) Valuation As Membership Expansion Targets Recurring Revenue

Membership expansion sets the stage for recurring revenue focus Six Flags Entertainment (FUN) is extending its Membership program to six more parks starting June 8, giving guests broader multi park access with low monthly payments and putting recurring revenue squarely in focus. For you as an investor, this type of membership expansion matters because it shifts more of the company’s business toward ongoing payments, rather than relying solely on individual ticket sales or seasonal spikes in...
NYSE:VIA
NYSE:VIASoftware

Via Transportation Probe Raises Questions On Disclosures And Investor Risk Profile

Securities law firm announces investigation into Via Transportation (NYSE:VIA) for potential securities law violations. Focus of the probe is on whether Via Transportation made inaccurate statements about its financials and business operations. Investigation could have implications for current and prospective shareholders depending on its findings. Via Transportation, listed on the NYSE under ticker VIA, operates in the technology enabled transit and mobility services space, connecting...
NYSE:U
NYSE:USoftware

Unity Software (U) Valuation Check As Analyst Upgrades Follow Grow Ad Business Progress

Unity Software (U) is back in focus after recent analyst upgrades, including commentary on progress in its Grow advertising business and higher earnings estimates that together underline shifting expectations around the company’s execution and monetization. See our latest analysis for Unity Software. Unity’s recent analyst upgrades and improving sentiment around its Grow ad business sit alongside a mixed price story, with the stock’s 90 day share price return of 51.28% contrasting with a year...
NasdaqGM:KOD
NasdaqGM:KODBiotechs

Kodiak Sciences Zenkuda Trial Win Puts Cash Needs And Growth In Focus

Kodiak Sciences (NasdaqGM:KOD) reported positive phase III results for its drug candidate Zenkuda in diabetic retinopathy. The company is accelerating regulatory submissions following the data readout, aiming to move the program toward potential approval. Kodiak Sciences is drawing fresh attention after this clinical update, with the stock at $34.16 and up strongly year to date, including a very large gain over the past 1 year. At the same time, shares are down 5.4% over the past week and...
NYSE:KVUE
NYSE:KVUEPersonal Products

Is It Time To Reassess Kenvue (KVUE) After Recent Share Price Weakness?

If you are wondering whether Kenvue's current share price offers value, or if you are better off waiting on the sidelines, this article breaks down what the market is pricing in and how that compares with several valuation checks. The stock recently closed at US$16.88 and has fallen 4.3% over the last week, 2.8% over the last month, and 2.5% year to date. The return over the past year is down 18.4% and down 24.1% over three years. Recent news flow around Kenvue has focused on its position as...
NasdaqGS:VRTX
NasdaqGS:VRTXBiotechs

Assessing Vertex Pharmaceuticals (VRTX) Valuation After Recent Share Price Gains And Renal Trial Progress

Stock performance snapshot and recent context Vertex Pharmaceuticals (VRTX) has drawn investor attention after recent trading left the stock with a 1 day gain of about 3.1%, while returns over the past 3 months show a decline of roughly 3.3%. See our latest analysis for Vertex Pharmaceuticals. That move comes on top of a 4.1% 1 month share price return and a 1 year total shareholder return that is roughly flat, while the 5 year total shareholder return above 100% points to stronger long term...
NYSE:ALSN
NYSE:ALSNMachinery

Is It Time To Reassess Allison Transmission Holdings (ALSN) After Its Recent Share Price Swings

If you are wondering whether Allison Transmission Holdings at around US$118 a share still offers value, the starting point is understanding what the current price is really baking in. The stock has been volatile recently, with a 4.3% gain over the last week, a 7.1% decline over the last month, and returns of 19.6% year to date and 16.8% over the past year that may catch your eye. These moves sit against a backdrop of ongoing interest in capital goods companies and how investors are pricing...
NasdaqGM:SPWR
NasdaqGM:SPWRElectrical

SunPower (SPWR) Valuation Check As Stock Settled Interest Plan Seeks Greater Financial Flexibility

SunPower’s equity and debt moves SunPower (SPWR) has moved to close a US$40.7 million shelf registration and is now seeking to pay upcoming interest on its 2029 convertible notes in stock plus bonus shares instead of cash. This combination of equity capacity, proposed share-based interest payments, and a recent incremental investment from Fortis Capital is intended to give the company more room to manage liquidity through Q3 2026. See our latest analysis for SunPower. Recent announcements...
NYSE:CAG
NYSE:CAGFood

Do Inflation Pressures and Dividend Strains Hint at a Deeper Shift in Conagra’s (CAG) Strategy?

In recent days, Conagra Brands reported quarterly results with slightly lower year-over-year revenue that still exceeded analyst expectations, alongside mixed profit guidance affected by commodity cost pressures. At the same time, several analysts warned that persistent inflation and a high payout ratio could put Conagra’s dividend policy under scrutiny, even as insiders accepted additional equity awards. We’ll now examine how concerns about inflation-driven cost pressures and potential...
NasdaqGS:ELVN
NasdaqGS:ELVNPharmaceuticals

Assessing Enliven Therapeutics (ELVN) Valuation As Investors Await Phase 1 ELVN-001 Data And Analyst Support

Clinical data catalyst and recent stock move Enliven Therapeutics (ELVN) is back in focus after the company highlighted upcoming Phase 1 ENABLE trial data for ELVN-001 in chronic myeloid leukemia, set to be presented at the European Hematology Association Congress. The company plans a June 11 webcast to walk through the updated results. This, together with recent positive analyst commentary, has drawn fresh attention to a stock that is up 66.1% over the past year. See our latest analysis for...
NasdaqGS:MCHP
NasdaqGS:MCHPSemiconductor

Is It Too Late To Consider Microchip Technology (MCHP) After Its 48% Year To Date Surge?

If you are wondering whether Microchip Technology at around US$96.30 is still offering value or if the easier gains are behind it, this breakdown will help you weigh what the current price really implies. The stock is roughly flat over the past week with a 0.3% gain, a little softer over the last month with a 2.2% decline, yet stands out with returns of 48.1% year to date and 53.7% over the past year. Recent coverage has focused on Microchip Technology's role within the broader semiconductor...
NYSE:OMF
NYSE:OMFConsumer Finance

OneMain’s 2026 Consumer Loan ABS Deal Adds Funding And Valuation Insight

OneMain Holdings (NYSE:OMF) has launched its first consumer loan asset backed securities securitization of 2026. This transaction is the company's 32nd consumer loan ABS issuance since 2013. The new deal has attracted ratings coverage, adding a fresh data point for investors tracking OneMain's funding mix. For investors watching consumer finance, OneMain sits at the intersection of personal lending and structured credit. The company uses consumer loan ABS as a recurring funding tool. The...
NYSE:VEEV
NYSE:VEEVHealthcare Services

Veeva Systems (VEEV) Net Margin Improvement Tests Bullish Long‑Term Targets

Veeva Systems (VEEV) kicked off Q1 2027 with revenue of US$882.9 million and basic EPS of US$1.60, against a backdrop of trailing 12 month EPS of US$5.75 and total revenue of about US$3.3 billion that has been reported growing around 11.2% year over year. Over recent quarters, revenue has moved from US$759.0 million in Q1 2026 through US$835.9 million in Q4 2026 to US$882.9 million in Q1 2027, while basic EPS has shifted from US$1.40 to US$1.49 and then to US$1.60 over the same period,...
NasdaqGS:ALGM
NasdaqGS:ALGMSemiconductor

How Investors May Respond To Allegro MicroSystems (ALGM) Tapping Nvidia’s Extended AI Infrastructure Roadmap

Nvidia CEO Jensen Huang’s recent GTC Taipei keynote at Computex, which reframed the scale and duration of the AI chip cycle and confirmed its next data center platform, has renewed interest in AI-related semiconductor suppliers such as Allegro MicroSystems. This matters because Allegro’s exposure to automotive, industrial and data center power and sensing solutions ties its longer-term prospects more closely to how far AI infrastructure spending extends beyond core GPUs. With Allegro...
NasdaqGS:CGNT
NasdaqGS:CGNTSoftware

Cognyte Software (CGNT) Returns To Q1 Loss Challenging Profitability Progress Narrative

Cognyte Software (CGNT) opened Q1 2027 with revenue of US$105.5 million and a basic EPS loss of US$0.04, while the trailing twelve months show revenue of US$410.0 million and a basic EPS loss of US$0.04. Over recent quarters, revenue has moved from US$95.5 million in Q1 2026 to US$105.5 million in Q1 2027, as quarterly EPS has swung between a loss of US$0.07 and a profit of US$0.05. This sets up a picture where investors are likely to focus squarely on how the current loss profile is...
NasdaqGS:FIVE
NasdaqGS:FIVESpecialty Retail

Five Below (FIVE) Same Store Sales Surge To 22.7% Tests Bullish Growth Narratives

Five Below (FIVE) has kicked off Q1 2027 with total revenue of US$1.3 billion and basic EPS of US$2.23, setting the tone for a results season where profitability and scale are front of mind for investors. The company has seen revenue move from US$970.5 million in Q1 2026 to US$1.3 billion in Q1 2027, while quarterly basic EPS shifted from US$0.75 to US$2.23 over the same period. This gives you a clear view of how the top and bottom lines are tracking. With trailing 12 month EPS at US$7.99 and...
NasdaqCM:WSC
NasdaqCM:WSCConstruction

A Look At WillScot Holdings (WSC) Valuation After Quarterly Results Beat Analyst Expectations

WillScot Holdings (WSC) is back on investor radar after quarterly results came in ahead of analyst expectations on both revenue and earnings, with management pointing to continued progress on commercial and operational priorities. See our latest analysis for WillScot Holdings. At a share price of $26.48, the stock has a 1 month share price return of 15.94% and a 90 day share price return of 37.49%. However, the 1 year total shareholder return is down 2.35%, suggesting recent momentum is...
NYSE:KRMN
NYSE:KRMNAerospace & Defense

Karman Holdings’ Tripled $3b Pipeline Versus Lofty Valuation And Weak Momentum

Karman Holdings' active pipeline has tripled to around $3b since Q1 2025. The larger pipeline reflects higher demand across its aerospace and defense programs. This update highlights a material shift in Karman Holdings' future business opportunities. Karman Holdings (NYSE:KRMN) now has an active pipeline of about $3b, representing a significant change in its potential workload across aerospace and defense contracts. The stock last closed at $54.39 and is down 17.4% over the past week and...
NYSE:BHE
NYSE:BHEElectronic

Election Of New Director Puts Benchmark Electronics Governance In Focus

Benchmark Electronics (NYSE:BHE) shareholders elected David A. Moezidis to the Board of Directors at the company’s recent annual meeting. The board change introduces a new voice into Benchmark’s governance at a time when electronics manufacturing and engineering services continue to evolve. The appointment is a fresh corporate development that may influence future decisions on operations, capital allocation, and risk oversight. Benchmark Electronics focuses on providing engineering,...
NasdaqGS:TROW
NasdaqGS:TROWCapital Markets

Is It Time To Reconsider T. Rowe Price Group (TROW) After Its Recent 20.9% Gain?

If you are wondering whether T. Rowe Price Group at US$106.96 is priced attractively or not, the key question is how that tag compares with the company’s underlying value. The stock has returned 3.3% over the past week, 2.7% over the last month and 2.2% year to date, with a 20.9% return over the past year, while the 3 year return sits at 8.5% and the 5 year return reflects a 29.9% decline. Recent attention on T. Rowe Price Group has been shaped by ongoing interest in asset and wealth...
NasdaqGS:ONB
NasdaqGS:ONBBanks

A Look At Old National Bancorp (ONB) Valuation After New Shelf Registration Filings

Why Old National Bancorp Filed New Shelf Registrations Old National Bancorp (ONB) recently filed multiple shelf registrations covering common stock, debt, preferred stock, depositary shares, warrants, purchase contracts, and units, including a separate ESOP related common stock offering totaling US$216.9 million. These filings do not commit the company to issue securities immediately. Instead, they give management a framework to raise capital or restructure funding relatively quickly if and...